The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence
Open accessAbstract
Chronic obstructive pulmonary disease (COPD) is characterised by an inflammatory response by the lungs to inhaled substances such as cigarette smoking and air pollutants. In addition to the pulmonary features of COPD, several systemic effects have been recognised even after controlling for common aetiological factors such as smoking or steroid use. These include skeletal muscle dysfunction, cardiovascular disease, osteoporosis and diabetes. Individuals with COPD have significantly raised levels of several circulating inflammatory markers indicating the presence of systemic inflammation. This raises the issue of cause and effect. The role of tumour necrosis factor α in COPD is thought to be central to both lung and systemic inflammation and has been implicated in skeletal muscle dysfunction, osteoporosis and type 2 diabetes. It has been hypothesised that inflammation in the lung results in 'overspill' into the circulation causing systemic inflammation. There is supportive evidence that protein movement can occur from the lung surface to the systemic circulation. Evidence from inhaled substances such as air pollutants and cigarette smoke has demonstrated a temporal link between the inflammatory process in the lung and systemic inflammation. Also, studies have shown alterations in circulating inflammatory cells in patients with COPD compared with controls which may reflect the effects of inflammatory mediators (derived from the lung) on circulating cells or the bone marrow. This paper considers the concept of 'overspill' in depth, reviews the current evidence and highlights problems in generating direct evidence to support or refute this concept.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Gan, W. Q. (2004) · Thorax · doi:10.1136/thx.2003.019588 · Cited by 1,838
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Keatings, V. M., Collins, P. D., Scott, D. M., & Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564092 · Cited by 1,362
Mechanisms of Muscle Wasting — The Role of the Ubiquitin–Proteasome Pathway
Mitch, W. E., & Goldberg, A. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612193352507 · Cited by 1,166
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I., Tracy, R. P., & Heiss, G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,071
Systemic effects of chronic obstructive pulmonary disease
Agustí, A. G. N., Noguera, A., Sauleda, J., Sala, E., Pons, J., & Busquets, X. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00405703 · Cited by 1,045
SALVI, S., BLOMBERG, A., RUDELL, B., KELLY, F., SANDSTRÖM, T., HOLGATE, S. T., & FREW, A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.3.9709083 · Cited by 899
The Relationship Between Reduced Lung Function and Cardiovascular Mortality
Sin, D. D., Wu, L., & Man, S. F. P. (2005) · Chest · doi:10.1378/chest.127.6.1952 · Cited by 881
Systemic oxidative stress in asthma, COPD, and smokers
Rahman, I., Morrison, D., Donaldson, K., & MacNee, W. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887607 · Cited by 774
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α
Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N., Novack, D., Woodring, J., & Pacifici, R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11066 · Cited by 705 · cited 1×
“Furthermore, TNFα and IL-1 have been implicated in the pathophysiology of osteoporosis,”
Backgroundvan EEDEN, S. F., TAN, W. C., SUWA, T., MUKAE, H., TERASHIMA, T., FUJII, T., QUI, D., VINCENT, R., & HOGG, J. C. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.5.2010160 · Cited by 698
Mortality after hospitalization for COPD
Almagro, P., Calbo, E., Ochoa de Echaguïen, A., Barreiro, B., Quintana, S., Heredia, J. L., & Garau, J. (2002) · Chest · doi:10.1378/chest.121.5.1441 · Cited by 630
Particulate air pollution induces progression of atherosclerosis
Suwa, T., Hogg, J. C., Quinlan, K. B., Ohgami, A., Vincent, R., & van Eeden, S. F. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01715-1 · Cited by 611
Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality
Sin, D. D., & Man, S. F. P. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200404-032ms · Cited by 572
Airway goblet cells: responsive and adaptable front-line defenders
Rogers, D. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07091690 · Cited by 558
C-reactive Protein As a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease
Dahl, M., Vestbo, J., Lange, P., Bojesen, S. E., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-713oc · Cited by 543
Schols, A. M., Buurman, W. A., Staal van den Brekel, A. J., Dentener, M. A., & Wouters, E. F. (1996) · Thorax · doi:10.1136/thx.51.8.819 · Cited by 522
Li, Y.-P., Schwartz, R. J., Waddell, I. D., Holloway, B. R., & Reid, M. B. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.871 · Cited by 499
Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease.
Di Francia, M., Barbier, D., Mege, J. L., & Orehek, J. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.5.7952575 · Cited by 485
Seemungal, T., MacCallum, P., Paul, E., Donaldson, G., Bhowmik, A., Jeffries, D., Meade, T., & Wedzicha, J. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613998 · Cited by 447
Raised CRP levels mark metabolic and functional impairment in advanced COPD
Broekhuizen, R. (2005) · Thorax · doi:10.1136/thx.2005.041996 · Cited by 439
Skeletal muscle dysfunction in chronic obstructive pulmonary disease
Jeffery Mador, M., & Bozkanat, E. (2001) · Respiratory Research · doi:10.1186/rr60 · Cited by 425
Keatings, V. M., & Barnes, P. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032177 · Cited by 402
Activated T-Lymphocytes and Macrophages in Bronchial Mucosa of Subjects with Chronic Bronchitis
Saetta, M., Di Stefano, A., Maestrelli, P., Ferraresso, A., Drigo, R., Potena, A., Ciaccia, A., & Fabbri, L. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.2.301 · Cited by 383
Vernooy, J. H., Küçükaycan, M., Jacobs, J. A., Chavannes, N. H., Buurman, W. A., Dentener, M. A., & Wouters, E. F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2202023 · Cited by 379
Inflammatory Response and Body Composition in Chronic Obstructive Pulmonary Disease
EID, A. A., IONESCU, A. A., NIXON, L. S., LEWIS-JENKINS, V., MATTHEWS, S. B., GRIFFITHS, T. L., & SHALE, D. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.8.2008109 · Cited by 376
Tumor Necrosis Factor-α Drives 70% of Cigarette Smoke–induced Emphysema in the Mouse
Churg, A., Wang, R. D., Tai, H., Wang, X., Xie, C., & Wright, J. L. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-511oc · Cited by 348
Associated Loss of Fat-free Mass and Bone Mineral Density in Chronic Obstructive Pulmonary Disease
Bolton, C. E., Ionescu, A. A., Shiels, K. M., Pettit, R. J., Edwards, P. H., Stone, M. D., Nixon, L. S., Evans, W. D., Griffiths, T. L., & Shale, D. J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-754oc · Cited by 337
Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients.
de Godoy, I., Donahoe, M., Calhoun, W. J., Mancino, J., & Rogers, R. M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564110 · Cited by 334
Casaburi, R. H., Gosselink, R., Decramer, M., Dekhuijzen, R. P. N., Fournier, M., Lewis, M. I., Maltais, F., Oelberg, D., Reid, M. B., Roca, J., et al. (1999) · American Journal of Respiratory and Critical Care Medicine · Cited by 332
TAKABATAKE, N., NAKAMURA, H., ABE, S., INOUE, S., HINO, T., SAITO, H., YUKI, H., KATO, S., & TOMOIKE, H. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9903022 · Cited by 327
The Macrophage in Chronic Obstructive Pulmonary Disease
SHAPIRO, S. D. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.supplement_1.9 · Cited by 322
Nemmar, A. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.12.061 · Cited by 317
Becker, S., Soukup, J. M., Gilmour, M. I., & Devlin, R. B. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0330 · Cited by 312
The Human Bone Marrow Response to Acute Air Pollution Caused by Forest Fires
TAN, W. C., QIU, D., LIAM, B. L., NG, T. P., LEE, S. H., van EEDEN, S. F., D'YACHKOVA, Y., & HOGG, J. C. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9904084 · Cited by 284
Gadek, J. E., Klein, H. G., Holland, P. V., & Crystal, R. G. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110360 · Cited by 278
Systemic Microvascular Dysfunction and Inflammation after Pulmonary Particulate Matter Exposure
Nurkiewicz, T. R., Porter, D. W., Barger, M., Millecchia, L., Rao, K. M. K., Marvar, P. J., Hubbs, A. F., Castranova, V., & Boegehold, M. A. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8413 · Cited by 267
Enhanced neutrophil response in chronic obstructive pulmonary disease
Noguera, A. (2001) · Thorax · doi:10.1136/thorax.56.6.432 · Cited by 264
Chapter 5 Proinflammatory cytokines in CRP baseline regulation
(2009) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(09)48005-3 · Cited by 226
Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction
Tamagawa, E., Bai, N., Morimoto, K., Gray, C., Mui, T., Yatera, K., Zhang, X., Xing, L., Li, Y., Laher, I., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00048.2007 · Cited by 222
Alveolar Epithelium: Role in Lung Fluid Balance and Acute Lung Injury
Matthay, M. A., Robriquet, L., & Fang, X. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200501-009ac · Cited by 203
Surfactant protein A and surfactant protein D in health and disease
Mason, R. J., Greene, K., & Voelker, D. R. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.275.1.l1 · Cited by 179
Burnett, D., Hill, S., Chamba, A., & Stockley, R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91476-0 · Cited by 175
Self-citationInflammatory Mediators in Chronic Obstructive Pulmonary Disease
Chung, K. (2005) · Current Drug Target -Inflammation & Allergy · doi:10.2174/156801005774912806 · Cited by 170
C-Reactive Protein Levels and Survival in Patients With Moderate to Very Severe COPD
de Torres, J. P., Pinto-Plata, V., Casanova, C., Mullerova, H., Córdoba-Lanús, E., de Fuentes, M. M., Aguirre-Jaime, A., & Celli, B. R. (2008) · Chest · doi:10.1378/chest.07-2433 · Cited by 169
Rusznak, C., Mills, P. R., Devalia, J. L., Sapsford, R. J., Davies, R. J., & Lozewicz, S. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.4.3959 · Cited by 163
NOGUERA, A., BUSQUETS, X., SAULEDA, J., VILLAVERDE, J. M., MacNEE, W., AGUSTÍ, A. G. N., & Santos, W. T. T. A. O. C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9712092 · Cited by 159
Kony, S. (2004) · Thorax · doi:10.1136/thx.2003.015768 · Cited by 158
ANALYSIS OF AIR POLLUTION PARTICULATE-MEDIATED OXIDANT STRESS IN ALVEOLAR MACROPHAGES
Imrich, C.-A. W. G. A. (1998) · Journal of Toxicology and Environmental Health · doi:10.1080/009841098158683 · Cited by 153
Ishii, H., Hayashi, S., Hogg, J. C., Fujii, T., Goto, Y., Sakamoto, N., Mukae, H., Vincent, R., & van Eeden, S. F. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-87 · Cited by 153
Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients
Profita, M., GIORGI, R. D., Sala, A., Bonanno, A., Riccobono, L., Mirabella, F., Gjomarkaj, M., Bonsignore, G., Bousquet, J. J., & Vignola, A. M. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00892.x · Cited by 152
Masubuchi, T., Koyama, S., Sato, E., Takamizawa, A., Kubo, K., Sekiguchi, M., Nagai, S., & Izumi, T. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65704-5 · Cited by 140
Terashima, T., Wiggs, B., English, D. R., Hogg, J. C., & van Eeden, S. F. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.4.9105091 · Cited by 139
TNF-α inhibitors in asthma and COPD: We must not throw the baby out with the bath water
Matera, M. G., Calzetta, L., & Cazzola, M. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2009.10.007 · Cited by 138
Cigarette smoking and peripheral blood leukocyte differentials
Schwartz, J. D., & Weiss, S. T. (1994) · Annals of Epidemiology · doi:10.1016/1047-2797(94)90102-3 · Cited by 131
Sin, D. D., Leung, R., Gan, W., & Man, S. P. (2007) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-7-13 · Cited by 123
Biomarkers of Systemic Inflammation in Stable and Exacerbation Phases of COPD
Karadağ, F., Karul, A., Çildağ, O., Yilmaz, M., & Ozcan, H. (2008) · Lung · doi:10.1007/s00408-008-9106-6 · Cited by 122
Steiner, S. S., Pfützner, A., Wilson, B., Harzer, O., Heinemann, L., & Rave, K. (2002) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2002-19989 · Cited by 116
Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease
Barczyk, A., Pierzchała, W., Kon, O. M., Cosío, B. G., Adcock, I. M., & Barnes, P. J. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.013 · Cited by 114
Broekhuizen, R., Grimble, R. F., Howell, W. M., Shale, D. J., Creutzberg, E. C., Wouters, E. F. �., & Schols, A. M. W. J. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.5.1059 · Cited by 108
Imbalances Between Interleukin-1 and Tumor Necrosis Factor Agonists and Antagonists in Stable COPD
Sapey, E., Ahmad, A., Bayley, D., Newbold, P., Snell, N. J. C., Rugman, P., & Stockley, R. A. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9286-8 · Cited by 105
Self-citationAn increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD
Yasuda, N., Gotoh, K., Minatoguchi, S., Asano, K., Nishigaki, K., Nomura, M., Ohno, A., Watanabe, M., Sano, H., Kumada, H., et al. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90343-2 · Cited by 101
Cigarette Smoke Exposure Attenuates Cytokine Production by Mouse Alveolar Macrophages
Gaschler, G. J., Zavitz, C. C. J., Bauer, C. M. T., Skrtic, M., Lindahl, M., Robbins, C. S., Chen, B., & Stämpfli, M. R. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0053oc · Cited by 94
Bergmann, S., Siekmeier, R., Mix, C., & Jaroß, W. (1998) · Respiration Physiology · doi:10.1016/s0034-5687(98)00098-x · Cited by 79
Tracing the Origins of Autism: A Spectrum of New Studies
Szpir, M. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.114-a412 · Cited by 76
TNF-α antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease
Suissa, S., Ernst, P., & Hudson, M. (2007) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2007.03.003 · Cited by 71
Silica Particles Enhance Peripheral Thrombosis
Nemmar, A., Nemery, B., Hoet, P., van Rooijen, N., & Hoylaerts, M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1202oc · Cited by 71
A study of plasma proteins in the sol phase of sputum from patients with chronic bronchitis.
Stockley, R. A., Mistry, M., Bradwell, A. R., et al. (1979) · Thorax · doi:10.1136/thx.34.6.777 · Cited by 70
Self-citationComparison of Bone Mineral Density in Elderly Female Patients With COPD and Bronchial Asthma
Katsura, H., & Kida, K. (2000) · CHEST Journal · doi:10.1378/chest.117.5_suppl_1.280s · Cited by 70
Sapey, E., Bayley, D., Ahmad, A., Newbold, P., Snell, N. J. C., & Stockley, R. A. (2007) · Thorax · doi:10.1136/thx.2007.086751 · Cited by 69
Self-citationSauleda, J., García-Palmer, F., GONZÁLEZ, G., Palou, A., & Agustí, A. G. N. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9807079 · Cited by 65
A Comparison of Bone Mineral Density in Elderly Female Patients with COPD and Bronchial Asthma
Katsura, H., & Kida, K. (2002) · CHEST Journal · doi:10.1378/chest.122.6.1949 · Cited by 63
Systemic effects of chronic obstructive pulmonary disease
Halpin, D. M. G. (2007) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.1.1.75 · Cited by 41
The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk
Hage, F. G., & Szalai, A. J. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0020-z · Cited by 35
Determinants of BMI in patients with COPD
Karadağ, F., Karul, A., Çildağ, O., Altun, Ç., & Gurgey, O. (2004) · Respirology · doi:10.1111/j.1440-1843.2003.00533.x · Cited by 32
von Haehling, S., Hopkinson, N. S., Polkey, M. I., Niethammer, M., Anker, S. D., & Genth‐Zotz, S. (2009) · Wiener klinische Wochenschrift · doi:10.1007/s00508-009-1186-7 · Cited by 31
Correlation between serum biomarkers and BODE index in patients with stable COPD
Liu, S., Chin, C., Chin‐Chou, W. A. N. G., & Lin, M. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01608.x · Cited by 29
Alveolar macrophages are necessary for the systemic inflammation of acute alveolar hypoxia
González, N. C., Allen, J., Blanco, V. G., Schmidt, E. J., van Rooijen, N., & Wood, J. G. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00312.2007 · Cited by 28
Cited by
Chronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 972
New insights into the immunology of chronic obstructive pulmonary disease
Brusselle, G. G., Joos, G. F., & Bracke, K. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60988-4 · Cited by 776
Hypoxemia in patients with COPD: cause, effects, and disease progression
McNicholas, W., Kent, & Mitchell (2011) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s10611 · Cited by 434
Pulmonary-intestinal cross-talk in mucosal inflammatory disease
Keely, S., Talley, N. J., & Hansbro, P. M. (2012) · Mucosal Immunology · doi:10.1038/mi.2011.55 · Cited by 386
Anxiety and depression-Important psychological comorbidities of COPD.
Pumar, M., Gray, C. R., Walsh, J., Yang, I. A., Rolls, T., & Ward, D. L. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.09.28 · Cited by 272
Metadata
- Authors
- Sinden, N. J., & Stockley, R. A.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2010-07-13
- Volume
- 65
- Issue
- 10
- Pages
- 930-936
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2100277531
- Cited by
- 379
- References
- 80
- FWCI
- 19.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.